81 search results for Lung
Guidelines for Patients Translations
® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Arabic) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Arabic, Cancer: Early Stage Version 2024 (Arabic) Guidelines for Patients® Small Cell Lung Cancer, -Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Chinese) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Chinese) Guidelines
https://www.nccn.org/global/what-we-do/guidelines-for-patients-translationsPolicy Toolkit_September 2021
LungCancer MultipleMyeloma (Portuguese) Non-SmallCell LungCancer EnhancedLevel NCCN Digital
https://www.nccn.org/docs/default-source/oncology-policy-program/policy-toolkit_september-2021.pdf?sfvrsn=c54522e6_2Download the Understanding Immunotherapy Side Effects Infographic (English).
. Joints Joint pain or swelling, stiffness after rest, improvement with activity Lungs Shortness
https://www.nccn.org/docs/default-source/patient-resources/immunotherapy_infographic.pdf?sfvrsn=f92249ca_36NCCN Guidelines Panels
Lung Cancer Screening Panel, Non-Small Cell Lung Cancer, Small Cell Lung Cancer Panel
https://www.nccn.org/education-research/continuing-education-(ce)/nccn-guidelines-in-practice/nccn-guidelines-panelsInternational Adaptations
(English) Hodgkin Lymphoma Version 2.2025 (English) Non-Small Cell Lung
https://www.nccn.org/global/what-we-do/international-adaptationsScientific Publications
: 10.1038/s41416-020-0737-6. Epub 2020 Feb 10.https://pubmed.ncbi.nlm.nih.gov/32037403/ Lung Cancer Myall NJ, patients with advanced non-small cell lung cancer. J Thorac Dis 2024. doi: 10.21037/jtd-23https, With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked. Clinical Lung Cancer Published:May 10, 2023 DOI:https://doi.org/10.1016/j.cllc.2023.05.003. https://www.clinical-lung-cancer.com/article/S1525-7304
https://www.nccn.org/education-research/nccn-oncology-research-program/scientific-publicationsClinical Trials
-trastuzumab deruxtecan in advanced refractory gastrointestinal cancer patients Lung Cancer Yasir, EGFR Mutant Lung Cancer Nicholas Bodor, MD, PhD, MPH Fox Chase Cancer Center TH-138: Phase II
https://www.nccn.org/education-research/nccn-oncology-research-program/clinical-trialsWebinars for Patients
Small Cell Lung Cancer (2025) Why Should I Consider a Clinical Trial? (2025) Non-Small Cell Lung, , patient resources, breast cancer, lung cancer, recorded webinars, recorded patient webinar, myeloma
https://www.nccn.org/patientresources/patient-resources/patient-webinarsGuidelines for Patients
Version: 2022 Non-Small Cell Lung Cancer - Early and Locally, Lung Cancer - Metastatic Version: 2024, Adenocarcinoma Version: 2024 Small Cell Lung, Version: 2025 Lung Cancer Screening, cancer resources, lung cancer resources, immunotherapy information, lung cancer information, prostate
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsCollaborators
AssociationAmerican Cancer Society, Inc.American Head & Neck Society (AHNS)American Lung AssociationAmerican Lung Cancer Screening Initiative (ALCSI)American Thyroid AssociationAnal Cancer, QuebecFORCE: Facing Our Risk of Cancer EmpoweredFoundation for Women's CancerFree ME from Lung, Liver InstituteGlobal Resource for Advancing Cancer EducationGo2 Foundation for Lung CancerGood, Breast Cancer Research FoundationInternational Association for the Study of Lung Cancer (IASLC
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/collaboratorsTreatment by Cancer Type
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/treatment-by-cancer-typeDetection, Prevention, and Risk Reduction
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/detection-prevention-and-risk-reductionSupportive Care
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-careSpecific Populations
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/specific-populationsORP Grant History
lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in ovarian cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in small cell lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in early-stage non-small cell lung cancer, with afatinib in lung cancer Bristol-Myers Squibb Company and ImClone Systems Incorporated, , and bevaciumab, with or without atezolizumab, in lung cancer GlaxoSmithKline LLC – pre-clinical
https://www.nccn.org/education-research/nccn-oncology-research-program/orp-grant-historyResume Screening
Myeloproliferative Neoplasms Neuroblastoma Neuroendocrine and Adrenal Tumors Non-Small Cell Lung, Cutaneous Lymphomas Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung, , and Gastric Lung Cancer Screening Prostate Cancer Early Detection Adult Cancer, Effects: Immune Checkpoint Inhibitors Kidney Cancer Liver Cancer Lung Cancer Screening Mantle, Nasopharyngeal Cancer Nausea and Vomiting Neuroendocrine Tumors Non-Small Cell Lung Cancer - Early
https://www.nccn.org/covid-19/resume-screeningFramework for Resource Stratification Of NCCN Guidelines
Version 3.2023 NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer Basic
https://www.nccn.org/global/what-we-do/nccn-framework-for-resource-stratification-of-nccn-guidelinesPermission to Cite or Use NCCN Content
Lung Cancer Screening Management of Immunotherapy-Related Toxicities Melanoma: Cutaneous, Cell Lung Cancer Occult Primary Older Adult Oncology Ovarian Cancer/Fallopian Tube Cancer/Primary, Adenocarcinoma Small Cell Lung Cancer Smoking Cessation Soft Tissue Sarcoma Squamous Cell Skin Cancer, Neoplasms Neuroendocrine and Adrenal Tumors Non-Small Cell Lung Cancer Occult Primary Ovarian Cancer, Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentGuidelines Panels
Lung Cancer Screening Panel, Panel Non-Small Cell Lung Cancer, Small Cell Lung Cancer Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panels2023 Summit Report
• Kristen Santiago, LUNGevity • Lisa Schlager, FORCE
https://www.nccn.org/docs/default-source/oncology-policy-program/2023-summit-report.pdf?sfvrsn=9db11db7_2